T 0722/24 (Enzalutamide/MEDIVATION) of 09.07.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T072224.20250709
- Date of decision
- 9 July 2025
- Case number
- T 0722/24
- Online on
- 14 August 2025
- Petition for review of
- -
- Application number
- 20177837.0
- IPC class
- A61P 15/08A61P 43/00A61K 9/20A61P 35/00A61K 9/14A61K 31/4164A61P 13/08A61P 15/14C07D 233/86A61K 31/4166A61P 15/00A61K 9/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- FORMULATIONS OF ENZALUTAMIDE
- Applicant name
- Medivation Prostate Therapeutics LLC
Astellas Pharma Inc. - Opponent name
- SANDOZ AG
Zentiva k.s.
Dr. Schön, Neymeyr & Partner Patentanwälte mbB
Hamm&Wittkopp Patentanwälte PartmbB
STADA Arzneimittel AG
Synthon BV
Alfred E. Tiefenbacher (GmbH & Co. KG)
Maiwald GmbH
Accord Healthcare Ltd
Bülle Dr., Jan
Elkington and Fife LLP - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 115European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 76(1)European Patent Convention Art 83European Patent Convention Art 87(1)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 12(6)Rules of procedure of the Boards of Appeal Art 13(2)
- Keywords
- Late-filed evidence - admittance
Observations by third parties - admittance (no)
Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Priority - basis in priority document (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- T 1965/23
Order
For these reasons it is decided that:
The appeals are dismissed.